nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrimethamine—CYP2C8—Tamoxifen—pancreatic cancer	0.167	0.191	CbGbCtD
Pyrimethamine—CYP2C8—Erlotinib—pancreatic cancer	0.142	0.162	CbGbCtD
Pyrimethamine—CYP2C8—Fluorouracil—pancreatic cancer	0.123	0.14	CbGbCtD
Pyrimethamine—CYP2C9—Tamoxifen—pancreatic cancer	0.117	0.133	CbGbCtD
Pyrimethamine—CYP2D6—Tamoxifen—pancreatic cancer	0.107	0.122	CbGbCtD
Pyrimethamine—CYP2D6—Erlotinib—pancreatic cancer	0.0906	0.103	CbGbCtD
Pyrimethamine—CYP2C9—Fluorouracil—pancreatic cancer	0.0859	0.098	CbGbCtD
Pyrimethamine—CYP2D6—Doxorubicin—pancreatic cancer	0.0447	0.051	CbGbCtD
Pyrimethamine—DHFR—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00416	0.132	CbGpPWpGaD
Pyrimethamine—Toxic epidermal necrolysis—Erlotinib—pancreatic cancer	0.00269	0.0292	CcSEcCtD
Pyrimethamine—Pancytopenia—Tamoxifen—pancreatic cancer	0.00247	0.0269	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Sunitinib—pancreatic cancer	0.00232	0.0253	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Tamoxifen—pancreatic cancer	0.0023	0.0251	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Erlotinib—pancreatic cancer	0.00228	0.0248	CcSEcCtD
Pyrimethamine—Pancytopenia—Sunitinib—pancreatic cancer	0.00212	0.0231	CcSEcCtD
Pyrimethamine—DHFR—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.00209	0.0664	CbGpPWpGaD
Pyrimethamine—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.00197	0.0215	CcSEcCtD
Pyrimethamine—Erythema multiforme—Tamoxifen—pancreatic cancer	0.00197	0.0215	CcSEcCtD
Pyrimethamine—Erythema multiforme—Erlotinib—pancreatic cancer	0.00195	0.0212	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Gemcitabine—pancreatic cancer	0.00187	0.0203	CcSEcCtD
Pyrimethamine—Pancytopenia—Gemcitabine—pancreatic cancer	0.0017	0.0185	CcSEcCtD
Pyrimethamine—Erythema multiforme—Sunitinib—pancreatic cancer	0.00169	0.0184	CcSEcCtD
Pyrimethamine—Pancytopenia—Fluorouracil—pancreatic cancer	0.00167	0.0182	CcSEcCtD
Pyrimethamine—DHFR—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.00166	0.0527	CbGpPWpGaD
Pyrimethamine—Leukopenia—Tamoxifen—pancreatic cancer	0.00162	0.0177	CcSEcCtD
Pyrimethamine—DHFR—G1/S-Specific Transcription—TYMS—pancreatic cancer	0.0016	0.051	CbGpPWpGaD
Pyrimethamine—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.00158	0.0172	CcSEcCtD
Pyrimethamine—Haematuria—Gemcitabine—pancreatic cancer	0.00152	0.0166	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00145	0.0158	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00143	0.0156	CcSEcCtD
Pyrimethamine—Anorexia—Tamoxifen—pancreatic cancer	0.00141	0.0154	CcSEcCtD
Pyrimethamine—Anorexia—Erlotinib—pancreatic cancer	0.0014	0.0152	CcSEcCtD
Pyrimethamine—Leukopenia—Sunitinib—pancreatic cancer	0.00139	0.0151	CcSEcCtD
Pyrimethamine—DHFR—E2F transcription factor network—RBBP8—pancreatic cancer	0.00138	0.044	CbGpPWpGaD
Pyrimethamine—Erythema multiforme—Gemcitabine—pancreatic cancer	0.00135	0.0147	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.00132	0.0144	CcSEcCtD
Pyrimethamine—Decreased appetite—Tamoxifen—pancreatic cancer	0.00129	0.014	CcSEcCtD
Pyrimethamine—Decreased appetite—Erlotinib—pancreatic cancer	0.00127	0.0139	CcSEcCtD
Pyrimethamine—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PRSS1—pancreatic cancer	0.00127	0.0404	CbGpPWpGaD
Pyrimethamine—Thrombocytopenia—Sunitinib—pancreatic cancer	0.00124	0.0135	CcSEcCtD
Pyrimethamine—Anorexia—Sunitinib—pancreatic cancer	0.00121	0.0132	CcSEcCtD
Pyrimethamine—Pancytopenia—Docetaxel—pancreatic cancer	0.00121	0.0131	CcSEcCtD
Pyrimethamine—Leukopenia—Irinotecan—pancreatic cancer	0.00115	0.0125	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.00112	0.0122	CcSEcCtD
Pyrimethamine—Leukopenia—Gemcitabine—pancreatic cancer	0.00112	0.0122	CcSEcCtD
Pyrimethamine—Decreased appetite—Sunitinib—pancreatic cancer	0.0011	0.012	CcSEcCtD
Pyrimethamine—Leukopenia—Fluorouracil—pancreatic cancer	0.0011	0.0119	CcSEcCtD
Pyrimethamine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00109	0.0119	CcSEcCtD
Pyrimethamine—DHFR—One Carbon Metabolism—TYMS—pancreatic cancer	0.00108	0.0342	CbGpPWpGaD
Pyrimethamine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00105	0.0114	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00102	0.0111	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00102	0.0111	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.001	0.0109	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000997	0.0108	CcSEcCtD
Pyrimethamine—Anorexia—Irinotecan—pancreatic cancer	0.000996	0.0108	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00098	0.0107	CcSEcCtD
Pyrimethamine—Anorexia—Gemcitabine—pancreatic cancer	0.00097	0.0106	CcSEcCtD
Pyrimethamine—DHFR—Trans-sulfuration and one carbon metabolism—TYMS—pancreatic cancer	0.000967	0.0308	CbGpPWpGaD
Pyrimethamine—Erythema multiforme—Docetaxel—pancreatic cancer	0.000961	0.0105	CcSEcCtD
Pyrimethamine—Anorexia—Fluorouracil—pancreatic cancer	0.000954	0.0104	CcSEcCtD
Pyrimethamine—DHFR—E2F mediated regulation of DNA replication—TYMS—pancreatic cancer	0.000944	0.03	CbGpPWpGaD
Pyrimethamine—DHFR—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000944	0.03	CbGpPWpGaD
Pyrimethamine—Vomiting—Tamoxifen—pancreatic cancer	0.000942	0.0102	CcSEcCtD
Pyrimethamine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000935	0.0102	CcSEcCtD
Pyrimethamine—Vomiting—Erlotinib—pancreatic cancer	0.000932	0.0101	CcSEcCtD
Pyrimethamine—Decreased appetite—Irinotecan—pancreatic cancer	0.000908	0.00989	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000893	0.00972	CcSEcCtD
Pyrimethamine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000885	0.00963	CcSEcCtD
Pyrimethamine—Decreased appetite—Fluorouracil—pancreatic cancer	0.00087	0.00947	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000826	0.00899	CcSEcCtD
Pyrimethamine—Pancytopenia—Epirubicin—pancreatic cancer	0.000814	0.00886	CcSEcCtD
Pyrimethamine—Vomiting—Sunitinib—pancreatic cancer	0.000807	0.00878	CcSEcCtD
Pyrimethamine—Leukopenia—Docetaxel—pancreatic cancer	0.000792	0.00862	CcSEcCtD
Pyrimethamine—Hypersensitivity—Irinotecan—pancreatic cancer	0.00077	0.00838	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000757	0.00824	CcSEcCtD
Pyrimethamine—Pancytopenia—Doxorubicin—pancreatic cancer	0.000753	0.00819	CcSEcCtD
Pyrimethamine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000737	0.00803	CcSEcCtD
Pyrimethamine—Haematuria—Epirubicin—pancreatic cancer	0.000728	0.00793	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000722	0.00786	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000707	0.0077	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000701	0.00763	CcSEcCtD
Pyrimethamine—Anorexia—Docetaxel—pancreatic cancer	0.000689	0.00749	CcSEcCtD
Pyrimethamine—Haematuria—Doxorubicin—pancreatic cancer	0.000674	0.00734	CcSEcCtD
Pyrimethamine—Vomiting—Irinotecan—pancreatic cancer	0.000664	0.00723	CcSEcCtD
Pyrimethamine—Erythema multiforme—Epirubicin—pancreatic cancer	0.000648	0.00706	CcSEcCtD
Pyrimethamine—Vomiting—Gemcitabine—pancreatic cancer	0.000647	0.00704	CcSEcCtD
Pyrimethamine—DHFR—E2F mediated regulation of DNA replication—RB1—pancreatic cancer	0.00064	0.0204	CbGpPWpGaD
Pyrimethamine—Vomiting—Fluorouracil—pancreatic cancer	0.000636	0.00693	CcSEcCtD
Pyrimethamine—Decreased appetite—Docetaxel—pancreatic cancer	0.000628	0.00683	CcSEcCtD
Pyrimethamine—Erythema multiforme—Doxorubicin—pancreatic cancer	0.0006	0.00653	CcSEcCtD
Pyrimethamine—DHFR—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—AKT1—pancreatic cancer	0.000594	0.0189	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—SYCP1—pancreatic cancer	0.000542	0.0172	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—SOD2—pancreatic cancer	0.000538	0.0171	CbGpPWpGaD
Pyrimethamine—Leukopenia—Epirubicin—pancreatic cancer	0.000534	0.00582	CcSEcCtD
Pyrimethamine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000532	0.00579	CcSEcCtD
Pyrimethamine—DHFR—E2F transcription factor network—TYMS—pancreatic cancer	0.0005	0.0159	CbGpPWpGaD
Pyrimethamine—Leukopenia—Doxorubicin—pancreatic cancer	0.000494	0.00538	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000487	0.0053	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000477	0.00519	CcSEcCtD
Pyrimethamine—Anorexia—Epirubicin—pancreatic cancer	0.000464	0.00505	CcSEcCtD
Pyrimethamine—Vomiting—Docetaxel—pancreatic cancer	0.000459	0.005	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000451	0.00491	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000441	0.0048	CcSEcCtD
Pyrimethamine—DHFR—Retinoblastoma (RB) in Cancer—TYMS—pancreatic cancer	0.000435	0.0138	CbGpPWpGaD
Pyrimethamine—Anorexia—Doxorubicin—pancreatic cancer	0.00043	0.00468	CcSEcCtD
Pyrimethamine—Decreased appetite—Epirubicin—pancreatic cancer	0.000424	0.00461	CcSEcCtD
Pyrimethamine—DHFR—E2F transcription factor network—PLAU—pancreatic cancer	0.000413	0.0131	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism of nitric oxide—AKT1—pancreatic cancer	0.000411	0.0131	CbGpPWpGaD
Pyrimethamine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000392	0.00427	CcSEcCtD
Pyrimethamine—DHFR—G1/S Transition—TYMS—pancreatic cancer	0.000363	0.0115	CbGpPWpGaD
Pyrimethamine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000359	0.00391	CcSEcCtD
Pyrimethamine—DHFR—E2F transcription factor network—RB1—pancreatic cancer	0.000339	0.0108	CbGpPWpGaD
Pyrimethamine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000332	0.00362	CcSEcCtD
Pyrimethamine—DHFR—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000313	0.00996	CbGpPWpGaD
Pyrimethamine—Vomiting—Epirubicin—pancreatic cancer	0.00031	0.00337	CcSEcCtD
Pyrimethamine—DHFR—Mitotic G1-G1/S phases—TYMS—pancreatic cancer	0.000306	0.00973	CbGpPWpGaD
Pyrimethamine—DHFR—E2F transcription factor network—CDKN2A—pancreatic cancer	0.000298	0.00948	CbGpPWpGaD
Pyrimethamine—DHFR—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	0.000295	0.00937	CbGpPWpGaD
Pyrimethamine—Vomiting—Doxorubicin—pancreatic cancer	0.000287	0.00312	CcSEcCtD
Pyrimethamine—DHFR—Cell Cycle—RBBP8—pancreatic cancer	0.000278	0.00883	CbGpPWpGaD
Pyrimethamine—DHFR—G1/S Transition—RB1—pancreatic cancer	0.000246	0.00783	CbGpPWpGaD
Pyrimethamine—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—pancreatic cancer	0.000242	0.0077	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	0.000241	0.00768	CbGpPWpGaD
Pyrimethamine—DHFR—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	0.000219	0.00696	CbGpPWpGaD
Pyrimethamine—CYP2D6—Melatonin metabolism and effects—APOE—pancreatic cancer	0.000216	0.00687	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—PPP2R5B—pancreatic cancer	0.000216	0.00687	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	0.000215	0.00684	CbGpPWpGaD
Pyrimethamine—DHFR—Mitotic G1-G1/S phases—RB1—pancreatic cancer	0.000207	0.00659	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—TNF—pancreatic cancer	0.000204	0.00649	CbGpPWpGaD
Pyrimethamine—DHFR—E2F transcription factor network—MYC—pancreatic cancer	0.000202	0.00642	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—FOXM1—pancreatic cancer	0.000192	0.00612	CbGpPWpGaD
Pyrimethamine—DHFR—Mitotic G1-G1/S phases—CDKN2A—pancreatic cancer	0.000182	0.0058	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—TP53—pancreatic cancer	0.00018	0.00572	CbGpPWpGaD
Pyrimethamine—DHFR—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	0.000176	0.00558	CbGpPWpGaD
Pyrimethamine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000164	0.00522	CbGpPWpGaD
Pyrimethamine—DHFR—Mitotic G1-G1/S phases—CCND1—pancreatic cancer	0.000154	0.0049	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—ZNRF3—pancreatic cancer	0.00015	0.00478	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PRSS1—pancreatic cancer	0.00015	0.00478	CbGpPWpGaD
Pyrimethamine—DHFR—G1/S Transition—MYC—pancreatic cancer	0.000147	0.00466	CbGpPWpGaD
Pyrimethamine—DHFR—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	0.000144	0.00458	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—DTX1—pancreatic cancer	0.000136	0.00432	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PRSS1—pancreatic cancer	0.000126	0.004	CbGpPWpGaD
Pyrimethamine—DHFR—Mitotic G1-G1/S phases—MYC—pancreatic cancer	0.000124	0.00393	CbGpPWpGaD
Pyrimethamine—CYP2C8—Arachidonic acid metabolism—PTGS2—pancreatic cancer	0.000117	0.00371	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—DTX4—pancreatic cancer	0.000114	0.00362	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—TYMS—pancreatic cancer	0.000112	0.00357	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PPP2R5B—pancreatic cancer	0.000111	0.00352	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ARG2—pancreatic cancer	0.000109	0.00347	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—HEY2—pancreatic cancer	0.000107	0.00339	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—BRCA2—pancreatic cancer	0.000105	0.00335	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—TYMS—pancreatic cancer	0.0001	0.00319	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—HEY1—pancreatic cancer	9.87e-05	0.00314	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—TYMP—pancreatic cancer	9.54e-05	0.00303	CbGpPWpGaD
Pyrimethamine—CYP2C9—Arachidonic acid metabolism—PTGS2—pancreatic cancer	9.49e-05	0.00302	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—JAG2—pancreatic cancer	8.76e-05	0.00278	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—TERT—pancreatic cancer	8.74e-05	0.00278	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MEN1—pancreatic cancer	8.63e-05	0.00274	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—SLC2A2—pancreatic cancer	8.57e-05	0.00272	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—SHH—pancreatic cancer	8.23e-05	0.00262	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—IAPP—pancreatic cancer	8.13e-05	0.00259	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—HSPA1B—pancreatic cancer	7.8e-05	0.00248	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GLP1R—pancreatic cancer	7.69e-05	0.00244	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—RB1—pancreatic cancer	7.6e-05	0.00242	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—DPYD—pancreatic cancer	7.56e-05	0.0024	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—SLC2A2—pancreatic cancer	7.18e-05	0.00228	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—JAG1—pancreatic cancer	6.98e-05	0.00222	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—RB1—pancreatic cancer	6.8e-05	0.00216	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	6.68e-05	0.00213	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CD44—pancreatic cancer	6.64e-05	0.00211	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—HSPA1A—pancreatic cancer	6.59e-05	0.00209	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—CDKN2A—pancreatic cancer	5.98e-05	0.0019	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—CCND1—pancreatic cancer	5.65e-05	0.0018	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CD44—pancreatic cancer	5.56e-05	0.00177	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GCG—pancreatic cancer	5.33e-05	0.00169	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—SMAD4—pancreatic cancer	5.24e-05	0.00167	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—HES1—pancreatic cancer	5.12e-05	0.00163	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—CCND1—pancreatic cancer	5.05e-05	0.00161	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—STK11—pancreatic cancer	5.01e-05	0.00159	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—MYC—pancreatic cancer	4.53e-05	0.00144	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TERT—pancreatic cancer	4.48e-05	0.00143	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—TYMS—pancreatic cancer	4.31e-05	0.00137	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—HIF1A—pancreatic cancer	4.29e-05	0.00136	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TSC2—pancreatic cancer	4.28e-05	0.00136	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—APOE—pancreatic cancer	4.18e-05	0.00133	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—MYC—pancreatic cancer	4.05e-05	0.00129	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PRSS1—pancreatic cancer	3.89e-05	0.00124	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—NOTCH1—pancreatic cancer	3.86e-05	0.00123	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—EGF—pancreatic cancer	3.73e-05	0.00119	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—APOE—pancreatic cancer	3.5e-05	0.00111	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ARG2—pancreatic cancer	3.37e-05	0.00107	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—TP53—pancreatic cancer	3.33e-05	0.00106	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PIK3CD—pancreatic cancer	3.32e-05	0.00106	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PRSS1—pancreatic cancer	3.19e-05	0.00102	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PRSS1—pancreatic cancer	3.16e-05	0.00101	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3CG—pancreatic cancer	3.16e-05	0.00101	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PPARG—pancreatic cancer	3.05e-05	0.000971	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—TYMP—pancreatic cancer	2.95e-05	0.000937	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PIK3CB—pancreatic cancer	2.89e-05	0.00092	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PTGS2—pancreatic cancer	2.87e-05	0.000912	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3CD—pancreatic cancer	2.78e-05	0.000884	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ARG2—pancreatic cancer	2.77e-05	0.00088	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ARG2—pancreatic cancer	2.74e-05	0.000873	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—CTNNB1—pancreatic cancer	2.57e-05	0.000816	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PTEN—pancreatic cancer	2.5e-05	0.000795	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.43e-05	0.000773	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3CB—pancreatic cancer	2.42e-05	0.000771	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—TYMP—pancreatic cancer	2.42e-05	0.000769	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PTGS2—pancreatic cancer	2.4e-05	0.000764	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—TYMP—pancreatic cancer	2.4e-05	0.000763	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GLP1R—pancreatic cancer	2.38e-05	0.000755	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—DPYD—pancreatic cancer	2.34e-05	0.000743	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—SRC—pancreatic cancer	2.32e-05	0.000737	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—STAT3—pancreatic cancer	2.24e-05	0.000711	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—NRAS—pancreatic cancer	2.23e-05	0.000709	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	2.22e-05	0.000705	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.19e-05	0.000698	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.12e-05	0.000674	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PTEN—pancreatic cancer	2.09e-05	0.000666	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MYC—pancreatic cancer	2.08e-05	0.000661	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TGFB1—pancreatic cancer	2.07e-05	0.000659	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—EGFR—pancreatic cancer	2.03e-05	0.000646	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.98e-05	0.000629	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GLP1R—pancreatic cancer	1.95e-05	0.00062	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GLP1R—pancreatic cancer	1.93e-05	0.000615	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.93e-05	0.000614	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—KRAS—pancreatic cancer	1.92e-05	0.000611	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—DPYD—pancreatic cancer	1.92e-05	0.00061	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—DPYD—pancreatic cancer	1.9e-05	0.000605	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	1.82e-05	0.000579	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	1.8e-05	0.000574	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.79e-05	0.000568	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PIK3CA—pancreatic cancer	1.76e-05	0.000561	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.72e-05	0.000548	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CD44—pancreatic cancer	1.72e-05	0.000546	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.68e-05	0.000535	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.67e-05	0.00053	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GCG—pancreatic cancer	1.65e-05	0.000524	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—HRAS—pancreatic cancer	1.63e-05	0.000519	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.57e-05	0.000499	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—STK11—pancreatic cancer	1.55e-05	0.000492	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3CA—pancreatic cancer	1.48e-05	0.00047	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.45e-05	0.000462	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—AKT1—pancreatic cancer	1.44e-05	0.000458	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CD44—pancreatic cancer	1.41e-05	0.000448	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CD44—pancreatic cancer	1.4e-05	0.000445	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.37e-05	0.000435	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.36e-05	0.000431	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GCG—pancreatic cancer	1.35e-05	0.00043	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GCG—pancreatic cancer	1.34e-05	0.000426	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—TYMS—pancreatic cancer	1.33e-05	0.000423	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—STK11—pancreatic cancer	1.27e-05	0.000404	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—STK11—pancreatic cancer	1.26e-05	0.000401	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—AKT1—pancreatic cancer	1.21e-05	0.000384	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.18e-05	0.000376	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.09e-05	0.000348	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—TYMS—pancreatic cancer	1.08e-05	0.000345	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APOE—pancreatic cancer	1.08e-05	0.000344	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.03e-05	0.000326	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	9.77e-06	0.000311	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PPARG—pancreatic cancer	9.43e-06	0.0003	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APOE—pancreatic cancer	8.89e-06	0.000283	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APOE—pancreatic cancer	8.81e-06	0.00028	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	8.59e-06	0.000273	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.34e-06	0.000265	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	8.02e-06	0.000255	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	7.95e-06	0.000253	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PPARG—pancreatic cancer	7.74e-06	0.000246	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PPARG—pancreatic cancer	7.68e-06	0.000244	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	7.49e-06	0.000238	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PTGS2—pancreatic cancer	7.42e-06	0.000236	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	7.05e-06	0.000224	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	6.99e-06	0.000222	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PTEN—pancreatic cancer	6.47e-06	0.000206	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	6.15e-06	0.000196	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	6.1e-06	0.000194	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	6.09e-06	0.000194	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PTGS2—pancreatic cancer	6.04e-06	0.000192	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PTEN—pancreatic cancer	5.31e-06	0.000169	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PTEN—pancreatic cancer	5.27e-06	0.000168	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	4.57e-06	0.000145	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	3.75e-06	0.000119	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—AKT1—pancreatic cancer	3.73e-06	0.000119	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	3.72e-06	0.000118	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—AKT1—pancreatic cancer	3.06e-06	9.74e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—AKT1—pancreatic cancer	3.04e-06	9.65e-05	CbGpPWpGaD
